Long-term prognostic impact of cystatin c on acute coronary syndrome octogenarians with diabetes mellitus

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Fu, Zhenhong ^a   Xue, Hao ^a   Guo, Jun ^a   Chen, Lian ^a   Dong, Wei ^a   Gai, Luyue ^a   Liu, Hongbin ^a   Sun, Zhijun ^a   Chen, Yundai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Cystatin C; Diabetes mellitus; Octogenarian; Prognosis

Indexed keywords

CYSTATIN C; GLUCOSE; HEMOGLOBIN A1C;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHINESE; CHRONIC KIDNEY FAILURE; CLINICAL EVALUATION; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE;

ACUTE CORONARY SYNDROME; AGED, 80 AND OVER; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ANGIOGRAPHY; CYSTATIN C; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; ROC CURVE;

EID: 84886740169     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-157     Document Type: Article

References (34)

1. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950-2050. J Am Coll Cardiol 2000, 35:1067. 10.1016/S0735-1097(00)00561-1, 10732909.
2. Thomas MP, Moscucci M, Smith DE, Aronow H, Share D, Kraft P, Gurm HS. Outcome of contemporary percutaneous coronary intervention in the elderly and the very elderly: Insights from the blue cross blue shield of michigan cardiovascular consortium. Clin Cardiol 2011, 34:549-554. 10.1002/clc.20926, 21717474.
3. Saxena A, Dinh DT, Yap CH, Reid CM, Billah B, Smith JA, Shardey GC, Newcomb AE. Critical analysis of early and late outcomes after isolated coronary artery bypass surgery in elderly patients. Ann Thorac Surg 2011, 92:1703-1711. 10.1016/j.athoracsur.2011.05.086, 22051266.
4. Battistoni A, Rubattu S, Volpe M. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int J Cardiol 2012, 157:160-168. 10.1016/j.ijcard.2011.06.066, 21763018.
5. Pavkov ME, Knowler WC, Hanson RL, Williams DE, Lemley KV, Myers BD, Nelson RG. Comparison of serum cystatin c, serum creatinine, measured gfr, and estimated gfr to assess the risk of kidney failure in american indians with diabetic nephropathy. Am J Kidney Dis 2013, 62:33-41. 10.1053/j.ajkd.2012.11.044, 23347458.
6. Ferraro S, Marano G, Biganzoli EM, Boracchi P, Bongo AS. Prognostic value of cystatin c in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. Clin Chem Lab Med 2011, 49:1397-1404.
7. Qing X, Furong W, Yunxia L, Jian Z, Xuping W, Ling G. Cystatin c and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc Diabetol 2012, 11:108. 10.1186/1475-2840-11-108, 3473246, 22978689.
8. Meng L, Yang Y, Qi LT, Wang XJ, Xu GB, Zhang BW. Elevated serum cystatin c is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol 2012, 25:426-430. 10.5301/jn.5000020, 21928225.
9. Batra A, Kapoor A, Sharma RK, Agrawal N, Sinha A, Kumar S, Garg N, Tewari S, Goel PK. Association of plasma cystatin c levels with angiographically documented coronary artery disease in patients of indian origin. J Cardiol 2012, 59:182-189. 10.1016/j.jjcc.2011.11.013, 22266456.
10. Funayama A, Watanabe T, Tamabuchi T, Otaki Y, Netsu S, Hasegawa H, Honda S, Ishino M, Arimoto T, Takahashi H, Shishido T, Miyamoto T, Nitobe J, Kubota I. Elevated cystatin c levels predict the incidence of vasospastic angina. Circ J 2011, 75:2439-2444. 10.1253/circj.CJ-11-0008, 21785225.
11. Kiyosue A, Hirata Y, Ando J, Fujita H, Morita T, Takahashi M, Nagata D, Kohro T, Imai Y, Nagai R. Plasma cystatin c concentration reflects the severity of coronary artery disease in patients without chronic kidney disease. Circ J 2010, 74:2441-2447. 10.1253/circj.CJ-10-0158, 20921817.
12. Sahakyan K, Lee KE, Shankar A, Klein R. Serum cystatin c and the incidence of type 2 diabetes mellitus. Diabetologia 2011, 54:1335-1340. 10.1007/s00125-011-2096-6, 3290654, 21380596.
13. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Eur Heart J 2012, 33:2551-2567. 10.1093/eurheartj/ehs184, 22922414.
14. Zhang LX, Zuo L, Xu GB, Wang F, Wang M, Wang SY, Lv JC, Liu LS, Wang HY. Community-based screening for chronic kidney disease among populations older than 40 years in beijing. Nephrol Dial Transplant 2007, 22:1093-1099. 10.1093/ndt/gfl763, 17210584.
15. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease. J Am Soc Nephrol 2006, 17:2937-2944. 10.1681/ASN.2006040368, 16988059.
16. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606. 10.1016/S0002-9149(83)80105-2, 6823874.
17. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum A, Goodman SG, Flather MD. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345. 10.1001/archinte.163.19.2345, 14581255.
18. Peralta CA, Lee A, Odden MC, Lopez L, Zeki Al Hazzouri A, Neuhaus J, Haan MN. Association between chronic kidney disease detected using creatinine and cystatin c and death and cardiovascular events in elderly mexican americans: the sacramento area latino study on aging. J Am Geriatr Soc 2013, 61:90-95. 10.1111/jgs.12040, 23252993.
19. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL. Estimating glomerular filtration rate from serum creatinine and cystatin c. N Engl J Med 2012, 367:20-29. 10.1056/NEJMoa1114248, 22762315.
20. Madero M, Sarnak MJ. Association of cystatin c with adverse outcomes. Curr Opin Nephrol Hypertens 2009, 18:258. 10.1097/MNH.0b013e328326f3dd, 2890263, 19374014.
21. Zheng JY, Xiao YY, Yao Y, Han L. Is serum cystatin c an early predictor for acute kidney injury following cardiopulmonary bypass surgery in infants and young children?. Kaohsiung J Med Sci 2013, 29:494-499. 10.1016/j.kjms.2013.01.004, 24018153.
22. Taglieri N, Koenig W, Kaski JC. Cystatin c and cardiovascular risk. Clin Chem 2009, 55:1932-1943. 10.1373/clinchem.2009.128397, 19713275.
23. Woitas RP, Kleber ME, Meinitzer A, Grammer TB, Silbernagel G, Pilz S, Tomaschitz A, Weihrauch G, Dobnig H, Marz W, Scharnagl H. Cystatin c is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography: the ludwigshafen risk and cardiovascular health (luric) study. Atherosclerosis 2013, 111:1681-1687.
24. Patel D, Ahmad S, Silverman A, Lindsay J. Effect of cystatin c levels on angiographic atherosclerosis progression and events among postmenopausal women with angiographically decompensated coronary artery disease (from the women's angiographic vitamin and estrogen [wave] study). Am J Cardiol 2013, 24:119-126.
25. Doganer YC, Aydogan U, Aydogdu A, Aparci M, Akbulut H, Nerkiz P, Turker T, Cayci T, Barcin C, Saglam K. Relationship of cystatin c with coronary artery disease and its severity. Coron Artery Dis 2013, 24:119-126. 10.1097/MCA.0b013e32835b6761, 23211477.
26. Ge C, Ren F, Lu S, Ji F, Chen X, Wu X. Clinical prognostic significance of plasma cystatin c levels among patients with acute coronary syndrome. Clin Cardiol 2009, 32:644-648. 10.1002/clc.20672, 19938052.
27. Deo R, Shlipak MG, Ix JH, Ali S, Schiller NB, Whooley MA. Association of cystatin c with ischemia in patients with coronary heart disease. Clin Cardiol 2009, 32:E18-22.
28. Tayeh O, Rizk A, Mowafy A, Salah S, Gabr K. Cystatin-c as a predictor for major adverse cardiac events in patients with acute coronary syndrome. Egypt Heart J 2012, 64:87-95.
29. Kilic T, Oner G, Ural E, Yumuk Z, Sahin T, Bildirici U, Acar E, Celikyurt U, Kozdag G, Ural D. Comparison of the long-term prognostic value of cystatin c to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome. Atherosclerosis 2009, 207:552-558. 10.1016/j.atherosclerosis.2009.05.015, 19523634.
30. Manzano-Fernández S, López-Cuenca T, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F. Usefulness of β-trace protein and cystatin c for the prediction of mortality in non st segment elevation acute coronary syndromes. Am J Cardiol 2012, 110:1240-1248. 10.1016/j.amjcard.2012.06.027, 22818840.
31. Silva D, Cortez-Dias N, Jorge C, Marques JS, Carrilho-Ferreira P, Magalhaes A, Martins SR, Goncalves S, da Silva PC, Fiuza M, Diogo AN, Pinto FJ. Cystatin c as prognostic biomarker in st-segment elevation acute myocardial infarction. Am J Cardiol 2012, 109:1431-1438. 10.1016/j.amjcard.2012.01.356, 22356795.
32. Zidek W, Schrader J, Luders S, Matthaei S, Hasslacher C, Hoyer J, Zemmrich C, Bramlage P, Sturm CD, Paar WD. Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (adapt) study. Cardiovasc Diabetol 2012, 11:1. 10.1186/1475-2840-11-1, 3313888, 22230104.
33. Abdullatef W, Al-Aqeedi R, Dabdoob W, Hajar H, Bener A, Gehani A. Prevalence of unrecognized diabetes mellitus in patients admitted with acute coronary syndrome. Angiology 2013, 64:26-30. 10.1177/0003319711434054, 22550348.
34. Sethi SS, Akl EG, Farkouh ME. Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials. Curr Diab Rep 2012, 12:294-304. 10.1007/s11892-012-0272-9, 22528594.